Pulmonary

FDA grants clearance for treprostinil soft mist inhaler clinical trial

The new application could be the first approved treatment for pulmonary hypertension associated with COPD.

Featured

Hand writing 'Proof of Concept' in white chalk on a blackboard

COPD treatment falls short in phase 2 proof-of-concept trial

3D neon illustration of human lungs with blood vessels and highlighted virus particle on dark blue background

Mepolizumab reduces systemic corticosteroid exposure in COPD patients

Advocate for better air

Advocate for better air

July 21, 2026

Fluorescent microscopy image showing multi-colored biological particles and cellular structures with green, blue, purple, and red fluorescent markers on black background

Hidden immune cell unlocks novel treatment approach

October 29, 2026

Allergy skin prick test being performed on patient's arm with testing vials and materials visible

Allergy treatment shows promise in changing the course of asthma

October 29, 2026

The hidden burden of comorbidities in severe asthma care

October 29, 2026

Allergy skin prick test being performed on patient's arm with testing vials and materials visible

Allergy treatment shows promise in changing the course of asthma

The hidden burden of comorbidities in severe asthma care

Researchers launch $1.6 million study on ginger as potential asthma therapy

Scientists uncover key driver of severe asthma inflammation in Black children

FDA grants clearance for treprostinil soft mist inhaler clinical trial

COPD treatment falls short in phase 2 proof-of-concept trial

Mepolizumab reduces systemic corticosteroid exposure in COPD patients

Study reveals BMI's limitations in predicting COPD risk

Fluorescent microscopy image showing multi-colored biological particles and cellular structures with green, blue, purple, and red fluorescent markers on black background

Hidden immune cell unlocks novel treatment approach

Investigational treatment begins for heart-related PH

Identifying lung cancer a decade early

First approved pediatric pulmonary heart valve

Spotlight

Notable stories and studies

Pulmonary fibrosis insight

Pulmonary fibrosis insight

CDC vaccine schedules

CDC vaccine schedules

Advocate for better air

Advocate for better air

Investigational treatment begins for heart-related PH

Pulmonary artery denervation was performed on the first two U.S. patients enrolled in the PULSE-LHD clinical trial.

October 28, 2026

Glowing red heart with branching blood vessels and coronary arteries illustrated on transparent human torso

Identifying lung cancer a decade early

Blood-based approach discovered at the University of Hawai’i could be used in lung cancer assessment to predict risk prior to developing cancer.

October 22, 2026

Two researchers in blue lab coats examining samples in a laboratory setting with shelves of scientific equipment and supplies

First approved pediatric pulmonary heart valve

The FDA approval marks a milestone for children with congenital pulmonary valve disease.

October 22, 2026

Young boy in teal medical scrubs smiling while forming a red heart shape with his hands

Sponsored

Pulmonary fibrosis insight

Ascend Media

The 2026 report provides global pipeline therapies in various clinical trial stages.

August 10, 2026

Pulmonary fibrosis insight

Researchers launch $1.6 million study on ginger as potential asthma therapy

Exploring “food as medicine” may complement traditional treatments and support disease prevention and management.

October 21, 2026

Fresh ginger root and turmeric powder on wooden surface with measuring spoon

Scientists uncover key driver of severe asthma inflammation in Black children

Race remains a strong link to severe asthma even after accounting for social and environmental disparities.

October 21, 2026

Child using asthma inhaler outdoors with green foliage background

Global burden of COPD-associated heart failure is on the rise

A review of data from the Global Burden of Disease Study found China has the highest national burden, and worldwide prevalence is projected to double by 2050.

October 21, 2026

Elderly man relaxing on a purple floral sofa with a small dog beside him and potted flowers nearby

Sponsored

Pulmonary fibrosis insight

Ascend Media

The 2026 report provides global pipeline therapies in various clinical trial stages.

August 10, 2026

Pulmonary fibrosis insight

Data add support of tozorakimab for patients with COPD

Analysis from three key trials reinforces benefits to COPD patients across all blood eosinophil counts and stages of lung function severity.

October 21, 2026

Healthcare professional workspace with stethoscope, medical charts, smartphone, and digital health technology icons

Dosing begins in trial of novel COPD therapy

KIT2014 is an innovative, inhaled peptide therapy that was developed for COPD and other respiratory illnesses.

October 16, 2026

Digital medical visualization of glowing lungs in human body with health monitoring data panels and vital signs displays

Chronic respiratory disease burden on the rise in Western Pacific region

World Health Organization analysis finds COPD accounted for 75.3% of CRD-related disability-adjusted life years in 2023.

October 16, 2026

Vintage globe map showing Southeast Asia, Indonesia, Australia, and surrounding regions with geographical labels and a ruler overlay

Sponsored

Pulmonary fibrosis insight

Ascend Media

The 2026 report provides global pipeline therapies in various clinical trial stages.

August 10, 2026

Pulmonary fibrosis insight

Parental anxiety, uncertainty may hinder children’s asthma control

Physicians should support parents with education, confidence-building and emotional resilience to achieve better outcomes.

October 15, 2026

Woman holding toddler in modern office space with colleagues and plants in background

Severe asthma may affect the brain, not just the lungs

Scientists highlight growing awareness that the condition can impact other aspects of health beyond breathing difficulties.

October 15, 2026

Medical illustration of human head showing brain, skull, and nervous system with glowing orange highlights on dark background

Mosliciguat phase 2 clinical trial yields positive results

The investigational inhaled drug shows promise for treating pulmonary hypertension associated with interstitial lung disease.

October 15, 2026

Healthcare provider demonstrating asthma inhaler use to patient wearing red and white striped shirt

Severe asthma may affect the brain, not just the lungs

Scientists uncover key driver of severe asthma inflammation in Black children

Parental anxiety, uncertainty may hinder children’s asthma control

What your breath could reveal about lung cancer

Mepolizumab reduces systemic corticosteroid exposure in COPD patients

Chronic respiratory disease burden on the rise in Western Pacific region